A study identified CYP4F12 as a histone acetylation–responsive gene in esophageal cancer, showing increased expression following trichostatin A treatment through the p300-mediated acetylation of H3K18 and H3K27. This evidence concerns the gene CYP4F12 and esophageal cancer.